Publications by authors named "Minetta Liu"

Claim this Profile
M
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study.
Koji Ando, Atsushi Hamabe, Yoshiaki Nakamura, Jun Watanabe, Keiji Hirata, Minetta C Liu

Ann Surg· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial.
Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi, Akiko Chino, Minetta C Liu

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.
Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf, Samuel Rivero-Hinojosa, Ziad Ahmed, Minetta C Liu

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer.
Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, Stephanie Pedersen, Marian Tang, Minetta Liu

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor.
Natasha Honoré, George Laliotis, Vasily N Aushev, Sharlene Velichko, Charuta C Palsuledesai, Minetta C Liu

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Michael D Toboni, Elizabeth T Evans, Carly Bess Scalise, Melissa Hardesty, Tara Berman, Minetta C Liu

Gynecol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.
Clara Martínez-Vila, Cristina Teixido, Roberto Martín, Francisco Aya, Sumedha Sudhaman, Minetta C Liu

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study.
Ellery H Reason, Michael D Aiduk, Amanda L Nash, Susan G R McDuff, Derrick Renner, Minetta C Liu

Ann Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.
Anne Knisely, Yibo Dai, Graham L Barlow, Sanghoon Lee, Barrett Lawson, Minetta C Liu

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy.
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, Yu Deng, Megan Eisele, Minetta C Liu

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.
Rebecca Hassoun, Reuben Ben-David, John P Sfakianos, George Laliotis, Cherry Au, Minetta C Liu

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.
Peter W Ketch, Carly Bess Scalise, Fernando Recio, Tara Berman, Nicole Hook, Minetta C Liu

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer.
Stacey A Cohen, Vasily N Aushev, George Laliotis, Iktej S Jabbal, Arun Nagarajan, Minetta C Liu

Ann Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.
Neil Carleton, Alexander C Chang, Fangyuan Chen, Shannon Puhalla, Julia Foldi, Minetta C Liu

medRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Excision Specimens in Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative, Early-Stage Breast Cancer.
Aziza Nassar, Jodi Carter, Paige Innis, Andrea Pingitore Blacklock, Jennifer Racz, Minetta C Liu

JCO Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma.
Maen Abdelrahim, Alejandro Mejia, Abdullah Esmail, Juan Carlos Barrera Gutierrez, Mahmoud Ouf, Minetta C Liu

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer.
Justin Balko, Xiaopeng Sun, Ann Hanna, Andres Ocampo, Brandie Taylor, Minetta Liu

Res Sq· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study.
Aziz Zaanan, Audrey Didelot, Chloé Broudin, George Laliotis, Erik Spickard, Minetta C Liu

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.
Wolfgang Janni, Thomas W P Friedl, Tracy C Yab, Francois-Clément Bidard, Massimo Cristofanilli, Minetta C Liu

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.
Denise M Wolf, Christina Yau, Michael Campbell, Annuska Glas, Andrei Barcaru, Minetta Liu

JCO Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast.
Julia Foldi, Steffi Oesterreich, Antony Tin, Samuel Rivero-Hinojosa, Janie Fielder, Minetta C Liu

JCO Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study.
Shuta Ohara, Kenichi Suda, Sumedha Sudhaman, Akira Hamada, Masato Chiba, Minetta C Liu

JTO Clin Res Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.
Shogo Takei, Daisuke Kotani, George Laliotis, Kazuma Sato, Naoto Fujiwara, Minetta C Liu

Ann Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases.
Rachel Radigan, Caleb S Kao, Michael Krainock, Minetta C Liu, Vani Gupta

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases.
Rachel Radigan, Caleb S Kao, Michael Krainock, Minetta C Liu, Vani Gupta

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis